Target intelligence / Profile preview

Alcohol dehydrogenase (Drosophila melanogaster) (Adh)

Target
Adh
Molecular classification
Enzyme, Oxidoreductase, Short-chain dehydrogenase/reductase (SDR) family
01

Overview

Drosophila alcohol dehydrogenase (Adh) is a vital metabolic enzyme in the fruit fly Drosophila melanogaster, primarily responsible for the oxidation of alcohols to aldehydes and ketones using NAD+ as a cofactor [UniProt: P00334]. It belongs to the short-chain dehydrogenase/reductase (SDR) family and functions as a homodimer essential for the survival of larvae and adults in ethanol-rich environments, such as fermenting fruit [FlyBase: FBgn0000055]. While it is not a therapeutic target for human disease, Adh is one of the most extensively studied proteins in evolutionary biology and population genetics, serving as a primary model for understanding molecular adaptation and enzyme kinetics [PubMed: 6348851]. Research on Adh has provided fundamental insights into how single amino acid substitutions, such as the well-known Fast/Slow polymorphism, affect protein stability and catalytic efficiency under natural selection [PubMed: 16505479]. Although the enzyme can be inhibited by compounds like pyrazole, its significance remains centered on basic biological research and its role as a genetic marker rather than clinical pharmacology [PubMed: 7028476].

Other names
AdhAlcohol dehydrogenase-1ADH-7Drosophila melanogaster alcohol dehydrogenaseADH_DROME
02

Mechanism of action

Catalyzes the NAD+-dependent oxidation of primary and secondary alcohols to their corresponding aldehydes and ketones [UniProt: P00334].

03

Biological functions

Alcohol metabolismDetoxification of environmental ethanolOxidation-reduction processLarval development
04

Disease associations

None (Non-human protein)
05

Safety considerations

Not a human therapeutic targetEcological impact if targeted in wild populations via gene drives
06

Interacting drugs

Pyrazole

3 more in the full profile.

07

Biomarkers

Adh-Fast (Adh-F) allozymeAdh-Slow (Adh-S) allozyme

Beyond the preview

Go deeper on Alcohol dehydrogenase (Drosophila melanogaster) (Adh).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alcohol dehydrogenase (Drosophila melanogaster) (Adh).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call